Find upcoming presentations, industry seminars, conference appearances, CPE events, and symposiums near you!
Read Middle Market Executive’s article on how FORVIS can help clients excel in their business. See today.
There are seven key tax considerations that companies in the technology, life sciences, and services sectors should be mindful of as they look to the new year. Read more.
Check out some specific technology needs that companies should assess when considering whether to become an SEC registrant.
Implementation efforts for Accounting Standards Codification (ASC) 842, Leases, are now underway for private companies.
The Southeast Life Sciences Conference in May 2022 in Atlanta, Georgia focused on the new FDA Tap program to accelerate early-stage medtech. Read on here.
Are you prepared for the new SEC pay versus performance disclosure requirements for first quarter 2023?
This informative webinar will explore key tax provisions for businesses and individuals included in the Inflation Reduction Act and the CHIPS and Science Act.
Insights on the new mandatory capitalization requirement for research and development costs.
This webinar will provide a tax legislative update on IRC Section 174 including the requirements for capitalizing R&D costs and the implications on financials.
FORVIS may be a new name to some in the private equity space, but it is backed by strong legacies and driven by a focus on the future of the industry. Scott Linch and John Kmetz, practice leaders from FORVIS, were recently featured in an article…